デフォルト表紙
市場調査レポート
商品コード
1560832

N95マスクの世界市場:2024年~2031年

Global N95 Mask Market - 2024 - 2031


出版日
ページ情報
英文 181 Pages
納期
即日から翌営業日
カスタマイズ可能
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.64円
N95マスクの世界市場:2024年~2031年
出版日: 2024年09月23日
発行: DataM Intelligence
ページ情報: 英文 181 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポート概要

N95マスクの世界市場は2023年に26億5,000万米ドルに達し、2031年には52億7,000万米ドルに達する見込みで、予測期間2024-2031年のCAGRで9.2%の成長が予測されています。

N95マスクは、エアロゾルや健康被害をもたらす蒸気やガスの吸入を防止するための個人用保護具として使用される呼吸マスクの一種です。N95マスクはまた、コロナウイルス、SARS、H1N1などの空気中浮遊ウイルスのような微小浮遊感染因子の吸入を防止します。欧州規格によると、ろ過率は95%以上、内部への漏れは8%以下でなければなりません。

N95マスクは、コロナウイルス対策用として最も一般的で売れ筋の呼吸マスクとされ、建設、農業、ヘルスケア、金属・鉱業など多方面の産業で使用されているため、人気が高まっています。N95のNは"Non-Oil "の略で、油性の微粒子を含まない作業環境でも使用できることを示し、95は95%の効率であることを示します。3ミクロンのマスクは、粉塵、ミスト、ヒュームなどの汚染物質をろ過します。

市場力学:

促進要因

感染症および呼吸器系疾患の増加

感染症や呼吸器系疾患の有病率の上昇が市場の成長を促進します。結核、百日咳、鳥インフルエンザ、アデノウイルス感染症などの感染症は、N95マスクを着用することで予防することができます。例えば、WHOによると、2022年には合計130万人が結核で死亡しています。世界では、結核はCOVID-19に次ぐ感染症キラーである(HIVとAIDSを上回る)。2022年には、世界で推定1,060万人が結核に罹患し、その内訳は男性580万人、女性350万人、子供130万人です。結核はすべての国と年齢層に存在します。結核は治療可能であり、予防も可能です。

cdc.govによると、腸チフスは世界中で毎年推定1,100万~2,100万件、パラチフスは500万件発生しており、推定13万5,000~23万人が死亡しています。米国における腸チフス症例の約85%、パラチフス症例の92%が海外からの旅行者の間で発生しており、そのほとんどが南アジア(主にバングラデシュ、インド、パキスタン)からの帰国者です。

抑制要因

競合や市場の飽和、厳しい規制要件、原材料に関するサプライチェーンの混乱などの要因が市場の妨げになると予想されます。

市場セグメンテーション

世界のN95マスク市場は、製品、用途、タイプ、エンドユーザー、地域によって区分されます。

N95マスクの世界市場シェアは、標準N95呼吸器セグメントが約34.6%を占める

予測期間中、標準N95呼吸器セグメントが最大の市場シェアを占めると予想されます。このセグメントでは、政府規制の開発と需要の増加がこの市場を牽引すると思われます。

標準N95呼吸器は、顔に密着して空気中の粒子を効率的にろ過する呼吸保護装置です。呼吸器の縁は、鼻と口の周りを密閉するように設計されています。標準的なN95呼吸器は、着用者が空気中の微粒子ハザードにさらされるのを減らすのに役立つように設計されています。米国では、呼吸器は米国国立労働安全衛生研究所(NIOSH)によって試験・認証されています。NIOSHは、ろ過効率などの物理的・性能的特性に基づいて呼吸器を試験・認証しています。

地域別市場分析

北米がN95マスク世界市場シェアの約42.6%を占める

予測期間中、北米地域が最大の市場シェアを占めると予想されます。同地域では、感染症や呼吸器系疾患の罹患率が上昇し、人々の意識が高まっていることが市場の推進力となっています。

例えば、Center for Infectious Disease Research and Policyが2024年3月に掲載した記事によると、米国疾病予防管理センター(CDC)の新しいデータによると、米国の結核患者数は2023年に増加し、3年連続で増加しました。発表されたデータによると、2023年に米国で報告された結核患者数は9,615人で、2022年から16%増加し、2013年以来最も多い報告数となった。結核罹患率は10万人当たり2.9人で、2022年から15%増加しました。結核罹患率はすべての年齢層で増加し、5歳から14歳の小児で最大の増加がみられました。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 影響要因
    • 促進要因
      • 呼吸器疾患と感染症の流行増加
    • 抑制要因
      • 競合と市場の飽和状態
      • 厳しい規制要件
      • 原材料に関するサプライチェーンの混乱
    • 機会
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • 価格分析
  • 規制分析
  • アンメットニーズ
  • PESTEL分析
  • 特許分析
  • SWOT分析

第6章 製品別

  • 呼気弁あり
  • 呼気弁なし

第7章 用途別

  • 再利用可能
  • 使い捨て

第8章 タイプ別

  • 標準N95呼吸器
  • 手術用N95呼吸器

第9章 エンドユーザー別

  • 病院
  • 鉱業
  • 建設会社
  • 石油・ガス産業
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他南米
  • アジア太平洋
    • 中国
    • インド
    • 日本
    • 韓国
    • その他アジア太平洋地域
  • 中東・アフリカ

第11章 競合情勢

  • 競合シナリオ
  • 市況/シェア分析
  • M&A分析

第12章 企業プロファイル

  • Shawmut Corporation
    • 会社概要
    • 製品ポートフォリオと説明
    • 財務概要
    • 主な発展
  • 3M
  • Honeywell
  • Ambu A/S
  • Moldex-Metric Inc.
  • Alpha Pro Tech
  • Ohlone Press LLC
  • Teleflex
  • Kimberly-Clark-Corporation
  • The Gerson Company

第13章 付録

目次
Product Code: MD3607

Report Overview

The Global N95 Mask Market reached US$ 2.65 billion in 2023 and is expected to reach US$ 5.27 billion by 2031, growing at a CAGR of 9.2% during the forecast period 2024-2031.

An N95 is a type of respirator mask used as personal protective equipment for the prevention of inhaling aerosols as well as vapors or gases that are health hazards. N95 mask also protects against inhaling micro airborne infectious agents such as airborne viruses including coronavirus, SARS, H1N1, etc. According to the European standard, it should have a minimum of 95% filtration and a maximum of 8% leakage to the inside.

N95 masks are gaining popularity as it is considered the most common and best-selling type of respirator mask, for protection against the coronavirus, it is also used in versatile industries such as construction, agriculture, healthcare, metals & mining, and others. In N95, the N stands for "Non-Oil" and indicates that the mask can be used in a work environment without oil-based particulates, the 95 indicates that the mask has a 95% efficiency rate. The 3-micron mask filters out contaminants like specks of dust, mists, and fumes.

Market Dynamics: Drivers

Increasing prevalence of infectious and respiratory diseases

The rising prevalence of infectious and respiratory diseases propels the market growth. Infectious diseases such as tuberculosis, pertussis, avian influenza, and adenovirus infections can be prevented by wearing N95 masks. For instance, according to WHO, a total of 1.3 million people died from TB in 2022. Worldwide, TB is the second leading infectious killer after COVID-19 (above HIV and AIDS). In 2022, an estimated 10.6 million people fell ill with tuberculosis (TB) worldwide, including 5.8 million men, 3.5 million women and 1.3 million children. TB is present in all countries and age groups. TB is curable and preventable.

According to cdc.gov, an estimated 11-21 million cases of typhoid fever and 5 million cases of paratyphoid fever occurs worldwide each year, causing an estimated 135,000-230,000 deaths. Approximately 85% of typhoid fever and 92% of paratyphoid fever cases in the United States occur among international travelers; most are travelers returning from South Asia, primarily Bangladesh, India, and Pakistan.

Restraints

Factors such as competition and market saturation, stringent regulatory requirements, supplychain disruptions regarding raw materials are expected to hamper the market.

Market Segment Analysis

The global N95 mask market is segmented based on product, usage, type, end-user, and region.

The segment standard N95 respirator accounted for approximately 34.6% of the global N95 mask market share

The standard N95 respirator segment is expected to hold the largest market share over the forecast period. In this segment, the development of government regulation, and increasing demand would drive this market.

A standard N95 respirator is a respiratory protective device that fits closely to the face and filters airborne particles efficiently. The edges of the respirator are designed to seal around the nose and mouth. Standard N95 respirators are designed to help reduce the wearer's exposure to airborne particulate hazards. In the U.S., respirators are tested and certified by the U.S. National Institute of Occupational Safety and Health (NIOSH). NIOSH tests and certifies respirators based on their physical and performance characteristics, including filtration efficiency.

Market Geographical Analysis

North America accounted for approximately 42.6% of the global N95 mask market share

North America region is expected to hold the largest market share over the forecast period. The rising incidence of infectious and respiratory diseases, and growing awareness among people, in this region, help to propel the market.

For instance, according to an article posted by Center for Infectious Disease Research and Policy in March 2024, the number of tuberculosis (TB) cases in the United States climbed in 2023, the third straight year of increases, according to new data from the Centers for Disease Control and Prevention (CDC). The data published showed that 9,615 TB cases were reported in the United States in 2023, a 16% increase from 2022 and the highest number reported since 2013. The TB incidence rate of 2.9 cases per 100,000 persons represented a 15% increase from 2022. TB incidence increased in every age group, with the largest increase seen in children ages 5 to 14 years.

As in previous years, most reported TB cases in 2023 (76%) occurred in non-US-born residents. But case counts rose among both US-born and non-US-born residents, who saw increases of 9% and 18%, respectively. Among US-born persons with TB, 33% were Black, 27% Hispanic, 26% White, 6% Asian, 5% American Indian or Native Alaskan, and 3% Native Hawaiian or other Pacific Islander.

Market Segmentation

By Product

With Exhalation Valve

Without Exhalation Valve

By Usage

Reusable

Disposable

By Type

Standard N95 Respirator

Surgical N95 Respirator

By End-User

Hospitals

Mining Industries

Construction Firms

Oil & Gas Industries

Others

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

U.K.

France

Spain

Italy

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

South Korea

Rest of Asia-Pacific

Middle East and Africa

Market Competitive Landscape

The major global players in the global N95 mask market include Shawmut Corporation, 3M, Honeywell, Ambu A/S, Moldex-Metric Inc., Alpha Pro Tech, Ohlone Press LLC, Teleflex, Kimberly-Clark Corporation, and The Gerson Company among others.

Key Developments

In August 2022, Optrel, a leading manufacturer of respiratory protection, launched the P Air Clear, the world's first NIOSH-approved N95 respirator with a transparent window. Swiss-made with the highest quality material for comfort and function, the P Air Clear features a transparent window, a latex-free head harness, and an adjustable nose clip.

In April 2022, RB Sigma announced that its domestically manufactured N95 Filtering Facepiece Respirator was approved by the National Institute for Occupational Safety and Health (NIOSH).

Why Purchase the Report?

To visualize the global N95 mask market segmentation based on product, usage, type, end-user, and region, as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development

Excel data sheet with numerous data points of global N95 mask market level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping is available in Excel consisting of key products of all the major players.

The global N95 mask market report would provide approximately 51 tables, 54 figures, and 181 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

  • 3.1. Snippet by Product
  • 3.2. Snippet by Usage
  • 3.3. Snippet by Type
  • 3.4. Snippet by End-User
  • 3.5. Snippet by Region

4. Dynamics

  • 4.1. Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Prevalence of Respiratory and Infectious Diseases
    • 4.1.2. Restraints
      • 4.1.2.1. Competition and Market Saturation
      • 4.1.2.2. Stringent Regulatory Requirements
      • 4.1.2.3. Supply Chain Disruptions Regarding Raw Materials
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Force Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Pricing Analysis
  • 5.4. Regulatory Analysis
  • 5.5. Unmet Needs
  • 5.6. PESTEL Analysis
  • 5.7. Patent Analysis
  • 5.8. SWOT Analysis

6. By Product

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 6.1.2. Market Attractiveness Index, By Product
  • 6.2. With Exhalation Valve*
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 6.3. Without Exhalation Valve

7. By Usage

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 7.1.2. Market Attractiveness Index, By Usage
  • 7.2. Reusable*
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 7.3. Disposable

8. By Type

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 8.1.2. Market Attractiveness Index, By Type
  • 8.2. Standard N95 Respirator*
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 8.3. Surgical N95 Respirator

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals*
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
  • 9.3. Mining Industries
  • 9.4. Construction Firms
  • 9.5. Oil & Gas Industries
  • 9.6. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. U.S.
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. UK
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia-Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.7.1. China
      • 10.5.7.2. India
      • 10.5.7.3. Japan
      • 10.5.7.4. South Korea
      • 10.5.7.5. Rest of Asia-Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Usage
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
    • 10.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Company Profiles

  • 12.1. Shawmut Corporation *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Financial Overview
    • 12.1.4. Key Developments
  • 12.2. 3M
  • 12.3. Honeywell
  • 12.4. Ambu A/S
  • 12.5. Moldex-Metric Inc.
  • 12.6. Alpha Pro Tech
  • 12.7. Ohlone Press LLC
  • 12.8. Teleflex
  • 12.9. Kimberly-Clark-Corporation
  • 12.10. The Gerson Company (*LIST NOT EXHAUSTIVE)

13. Appendix

  • 13.1. About Us and Services
  • 13.2. Contact Us